A Trial of SHR6508 in Secondary Hyperparathyroidism

Clinical trial NCT05221008 · COMPLETED

Trial details

NCT number: NCT05221008
Sponsor: Shanghai Hengrui Pharmaceutical Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Secondary Hyperparathyroidism

Start date: 2022-03-10
Primary completion: 2023-07-07
Enrollment: 54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.